Stockscreener 앱 받기
35.77
1.76%
0.62
전일 마감가:
$35.15
열려 있는:
$35.17
하루 거래량:
653.89K
Relative Volume:
0.78
시가총액:
$2.83B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-47.69
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
-1.16%
1개월 성능:
-16.91%
6개월 성능:
+16.59%
1년 성능:
-9.65%
1일 변동 폭
$35.17
$36.53
1주일 범위
$34.17
$37.57
52주 변동 폭
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
35.77 | 2.78B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Pharma News: What is the next catalyst for Veracyte IncJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Veracyte (NASDAQ:VCYT) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Is Veracyte Inc. exposed to currency risks2025 Valuation Update & Daily Profit Maximizing Trade Tips - mfd.ru
56,756 Shares in Veracyte, Inc. $VCYT Bought by Thrivent Financial for Lutherans - MarketBeat
Is Veracyte Inc.’s ROIC above industry averageTrade Volume Report & Free Community Consensus Stock Picks - mfd.ru
Can Veracyte Inc. expand into new marketsJuly 2025 Selloffs & Real-Time Buy Signal Notifications - mfd.ru
Why Veracyte Inc. stock is considered a top pickJuly 2025 Final Week & Reliable Entry Point Trade Alerts - mfd.ru
Veracyte, Inc. $VCYT Stock Holdings Increased by Allianz Asset Management GmbH - MarketBeat
Sentiment Watch: What are the future prospects of Veracyte Inc2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Is Veracyte (VCYT) Pricing Reflect Future Cash Flows After Multi Year Share Price Slide - Yahoo Finance
Federated Hermes Inc. Sells 52,039 Shares of Veracyte, Inc. $VCYT - MarketBeat
Principal Financial Group Inc. Boosts Stake in Veracyte, Inc. $VCYT - MarketBeat
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $4.78 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN) - The Globe and Mail
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - BioSpace
Veracyte is Now Oversold (VCYT) - Nasdaq
Here's Why Veracyte (VCYT) is a Strong Growth Stock - Yahoo Finance
Aug Fed Impact: Can Veracyte Inc generate free cash flowJuly 2025 Earnings & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Veracyte’s Growth Story Hit A Valuation Wall - Finimize
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Hold" from Analysts - MarketBeat
Stock Report: Is Veracyte Inc stock a top performer YTD2025 Price Targets & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Improved Revenues Required Before Veracyte, Inc. (NASDAQ:VCYT) Shares Find Their Feet - 富途牛牛
Targets Report: What makes Veracyte Inc. stock attractive today2025 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test - Nasdaq
Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - Finviz
Can Veracyte Inc. ride the EV waveQuarterly Portfolio Report & Precise Buy Zone Identification - mfd.ru
Earnings Miss: Can Veracyte Inc expand into new marketsEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader With 17.49% Potential Upside - DirectorsTalk Interviews
Why Veracyte (VCYT) is poised to beat earnings estimates again - MSN
Veracyte, Inc. (VCYT) sees analyst support as Guggenheim reaffirms buy rating - MSN
Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again - Prime Publishers, Inc.
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate - Chartmill
AEGON ASSET MANAGEMENT UK Plc Has $14.06 Million Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Stronger‑Than‑Expected Revenue Outlook Might Change The Case For Investing In Veracyte (VCYT) - simplywall.st
Swing Trade: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantJuly 2025 WrapUp & Verified Entry Point Signals - baoquankhu1.vn
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Assessing Veracyte (VCYT) Valuation As Recent Momentum Meets An Expensive P/E Ratio - Sahm
Is Veracyte’s (VCYT) Confident Double‑Digit Revenue Outlook Altering The Investment Case For Investors? - Yahoo Finance
Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating - Finviz
Centene Expands Palliative Care Access in Ohio Through Tuesday Health - Nasdaq
QRG Capital Management Inc. Sells 106,926 Shares of Veracyte, Inc. $VCYT - MarketBeat
S P Trends: Is Veracyte Inc showing insider buyingTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
State of Alaska Department of Revenue Takes $1.50 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Trade Recap: Is Veracyte Inc stock a value trapJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn
Veracyte: Profitable, De-Risked, And Ready To Run (NASDAQ:VCYT) - Seeking Alpha
Sumitomo Mitsui Trust Group Inc. Sells 165,094 Shares of Veracyte, Inc. $VCYT - MarketBeat
SG Americas Securities LLC Increases Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (NASDAQ:VCYT) Cut to Hold at Zacks Research - MarketBeat
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.13%
자본화:
|
볼륨(24시간):